EV Biologics, Inc. (OTCPK: YECO)
Health Care · Biotechnology · US
$—
— today · — 1Y
EV Biologics, Inc. (OTCPK: YECO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.09K and employs 284 people.
trading between 0.00 and 0.11.
Tweenvest scores EV Biologics, Inc. across four factors: quality 64/100, value 47/100, growth 0/100. Its strongest factor is quality.
YECO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.09K
- Revenue (TTM)
- $9.47M
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- 0.47
- 52-week high
- $0.11
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.23M
- Employees
- 284
- Next earnings
- —
About EV Biologics, Inc.
EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its proprietary, versatile EV platform to engineer innovative vaccines, treatments, and potential cures. Beyond EVs, it also dedicates efforts to cultivating human mesenchymal and other stem cells, as well as various cell-derived products, to address the needs of the cosmetic and biopharmaceutical industries. Founded in 2011, the firm was originally known as Yulong Eco-Materials Limited until its rebranding to EV Biologics, Inc. in August 2020, and it operates from its headquarters in Cheyenne, Wyoming.
- ISIN
- US9884971030
- Founded
- 2011
- Listed since
- Jun 29, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.